This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignees: Isis Pharmaceuticals, Inc., Merrion Research III Limited. Active years: 2010-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2011
Title: Innovations by Mangaraju Gudipati
Introduction
Mangaraju Gudipati is an accomplished inventor based in Yardley, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of permeation enhancers. With a total of 2 patents to his name, his work has the potential to impact drug delivery systems significantly.
Latest Patents
Mangaraju's latest patents include innovative pharmaceutical compositions. The first patent focuses on antisense permeation enhancers, which comprise an antisense oligonucleotide and a permeation enhancer featuring a multi-carbon backbone with functional groups and side chains. The second patent addresses permeation enhancers that consist of a drug and a similar multi-carbon backbone structure, enhancing the efficacy of drug delivery.
Career Highlights
Throughout his career, Mangaraju has worked with notable companies such as Merrion Research III Limited and Isis Pharmaceuticals, Inc. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to groundbreaking research.
Collaborations
Mangaraju has collaborated with esteemed colleagues, including Araz A Raoof and David C Bibby. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in their respective fields.
Conclusion
Mangaraju Gudipati's contributions to pharmaceutical innovations through his patents and collaborations highlight his role as a significant inventor in the industry. His work continues to pave the way for advancements in drug delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
